Abstract
The title compound tert-butyl 4-(5-(3-fluorophenyl)-1,2,4-oxadiazol-3-yl)piperazine-1-carboxylate was synthesized by condensation reaction between carbamimide and 3-fluorobenzoic acid in the presence of 3-(3-dimethylaminopropyl)carbodiimide hydrochloride and hydroxybenzotriazole under basic condition. It was characterized by spectroscopic evidences such as LCMS, 1H NMR, 13C NMR, IR, and CHN elemental analysis. The structure was further confirmed by single crystal XRD data. The title compound, C17H21FN4O3, crystallized in the monoclinic crystal system and P21/c space group with the unit cell parameters a = 14.281(3) Å, b = 11.579(2) Å, c = 11.331(2) Å, β = 110.674(6)°, Z = 4, and V = 1753.0(6) Å3. In the structure, the molecules are linked through weak C‒H···O intermolecular interactions along [010], and aromatic π–π stacking interactions (centroid-centroid distance = 3.7456(15)Å generate a three-dimensional architecture. The compound was screened for its in vitro antibacterial and anthelmintic activity. The compound exhibited poor antibacterial and moderate anthelmintic activity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
